Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BL-P1654: a bacteriostatic penicillin?

C C Sanders, W E Sanders

    Antimicrobial Agents and Chemotherapy
    |April 11, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Discrepancies in BL-P1654

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cefepime : The Last Generation or the First Enhanced-Potency Broad Spectrum Cephalosporin?

    Clinical drug investigation·2016
    Same author

    Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital.

    Journal of clinical microbiology·2001
    Same author

    Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae.

    The Journal of antimicrobial chemotherapy·2001
    Same author

    Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
    Same author

    Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries.

    Journal of the American College of Cardiology·2000
    Same author

    Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa.

    Journal of clinical microbiology·2000

    Area of Science:

    • Microbiology
    • Pharmacology
    • Bacterial Resistance

    Background:

    • Discrepancies between minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) for BL-P1654 against Pseudomonas were noted.
    • These discrepancies were not observed with carbenicillin, a related penicillin antibiotic.

    Purpose of the Study:

    • To investigate the kinetics of bacterial killing by BL-P1654 and carbenicillin.
    • To explain the observed discrepancies between inhibitory and bactericidal concentrations of BL-P1654.

    Main Methods:

    • Comparative evaluation of bacterial killing kinetics for BL-P1654 and carbenicillin against Pseudomonas.
    • Utilized sensitive subculturing techniques to detect resistant bacterial populations.

    Main Results:

    Related Experiment Videos

    • Both BL-P1654 and carbenicillin exhibited penicillin-characteristic killing kinetics, initiating simultaneously with bacterial growth.
    • Kill curves revealed a small, macroscopically undetectable population of Pseudomonas cells resistant to BL-P1654.
    • This resistance pattern was not observed with carbenicillin.

    Conclusions:

    • The discrepancies in BL-P1654's inhibitory vs. bactericidal concentrations are attributed to a small subpopulation of resistant cells.
    • This resistance was detectable only through sensitive subculturing, not standard macroscopic observation.
    • The findings clarify the antimicrobial activity of BL-P1654 and highlight the importance of sensitive detection methods for resistance.